Adult HGBCL, NOS patients have a poor prognosis compared with de novo DLBCL, and have frequent PIM1 mutations, which are not seen in HBGCL, NOS, with a BL signature.6 This evidence concerns the gene PIM1 and Burkitt lymphoma.